Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Peter Strang's publication output changed over time?
ScholarIQpublication output · 2000–2024
Output declined50% over the shown period — from 2 works in 2000 to 1 in 2024.
2
1
1
2
1
1
1
1
1
200020012002200420062007201220202024
What are the most-cited papers on Peter Strang?
ScholarIQmost cited works
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
Sten Nilsson, Lars Franzén, Christopher Parker, Christopher Tyrrell, René Blom, Jan Tennvall, Bo Lennernäs, Ulf Petersson, Dag Clement Johannessen, M. Sokal, K. Pigott, Jeffrey Yachnin, Michael Garkavij, Peter Strang, Johan Harmenberg, B. Bolstad, Øyvind S. Bruland
The Lancet Oncology. 2007493 Citations
A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
Sten Nilsson, Peter Strang, A. Aksnes, Lars Franzén, Patrick Olivier, A Pecking, J. Staffurth, S. Vasanthan, Charlotte Andersson, Øyvind S. Bruland
European Journal of Cancer. 2012246 CitationsOPEN ACCESS
Spiritual thoughts, coping and ‘sense of coherence’ in brain tumour patients and their spouses
Susan Strang, Peter Strang
S122377002. 2001226 Citations
Breakthrough pain in malignant and non‐malignant diseases: a review of prevalence, characteristics and mechanisms
Kristina B. Svendsen, Steen Andersen, Sigurður Árnason, Staffan Arnér, Harald Breivik, Tarja Heiskanen, Eija Kalso, Ulf E. Kongsgaard, Per Sjøgren, Peter Strang, Flemming W. Bach, Troels S. Jensen
European Journal of Pain. 2004190 Citations
Death anxiety in brain tumour patients and their spouses
Susan Adelbratt, Peter Strang
S122377002. 2000180 Citations
Related on ScholarIQ
Karolinska Institutet
Institution
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
Paper
A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
Paper
Spiritual thoughts, coping and ‘sense of coherence’ in brain tumour patients and their spouses
Paper
Breakthrough pain in malignant and non‐malignant diseases: a review of prevalence, characteristics and mechanisms
Paper
Death anxiety in brain tumour patients and their spouses
Paper